This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print this page


    Page   1/3   
  • Three takeaways on compliance deadlines for derivatives rules under the Dodd-Frank Act
    Read our high-level summary to better understand and prepare for complex rules and reforms.
  • A view of the U.S. health care system
    Deloitte surveyed thousands of consumers, physicians and employers about their opinions of health care reform. Explore the resulting infographic.
  • Dodd-Frank Act two-year anniversary
    Learn how the legislation has already influenced the financial services and banking industries, and explore what may lie ahead.
  • Navigating the International Classification of Diseases (ICD)-10 transition
    The transition to the ICD-10 coding set presents opportunities, benefits and challenges that health care providers should address.
  • The Center for Regulatory Strategies
    Through Deloitte's Center for Regulatory Strategies, executives can keep a sharp eye on regulatory developments and their implications for specific industries.
  • Integrated reporting: The new big picture
    This framework is responding to the changing expectations not just of disclosure but also of businesses’ wider responsibilities in society.
  • Tax rate outlook for high-income individuals
    Examine the prospects of Congress changing tax rates on earned income and income from capital gains and qualified dividends.
  • Reforming your people strategy
    A health plan’s approach to health reform needs a focused people strategy. Explore five priorities leaders should consider.
  • I’m OK, you’re OK ... but will we be all right?
    With the U.S. health care system undergoing massive change, some stakeholders are taking bold, innovative steps.
  • Moving target: The impact of U.S. health care reform on the life sciences industry
    The impact of U.S. health care reform on the life sciences industry will be significant and pervasive.
  • Page   1/3